Hyperoxia-induced lung injury is a key contributor to the development of bronchopulmonary dysplasia in preterm infants, primarily through oxidative stress and impaired antioxidant defense mechanisms.
Objective
To evaluate the protective effects of N-acetylcysteine (NAC) and combined vitamin E and C therapy on oxidative stress, antioxidant capacity, and lung histopathology in a neonatal rat model of hyperoxia-induced lung injury.
Methods
A total of 36 neonatal rats were randomly assigned to four groups: control (room air, n = 9), hyperoxia (n = 9), hyperoxia + NAC (n = 8), and hyperoxia + vitamin E + C (n = 10). Hyperoxia exposure (90% ± 10% O2) was maintained from postnatal days 3–14. Treatments were administered intraperitoneally (NAC 150 mg/kg/day, vitamin E 25 IU/day, vitamin C 1 mg/kg/day). Oxidative stress parameters (TOS, OSI, and LOOH), antioxidant markers (TAS, paraoxonase, and arylesterase), and histopathological findings were evaluated in serum and lung tissue.
Results
Hyperoxia significantly increased oxidative stress markers, with higher TOS levels observed in both serum and lung tissue compared to the control group (p < 0.001). NAC and vitamin E + C treatments significantly increased TAS levels compared to the hyperoxia group (p < 0.05). Serum OSI levels were significantly reduced in both treatment groups (p = 0.002 and p = 0.032). Additionally, arylesterase levels were significantly higher in the vitamin group compared to all other groups (p < 0.001). Histopathological evaluation demonstrated reduced inflammatory cell infiltration and lower fibrosis scores in the treatment groups.
Conclusion
N-acetylcysteine and combined vitamin E and C therapy attenuate hyperoxia-induced lung injury by reducing oxidative stress and improving lung histopathology in neonatal rats. These findings support antioxidant strategies as adjunctive approaches for BPD-related lung injury.
DankharaNHollaIRamaraoS, et al.Bronchopulmonary dysplasia: pathogenesis and pathophysiology. J Clin Med2023; 12(13): 4207. https://doi.org/10.3390/jcm12134207
2.
GilfillanMBhandariABhandariV. Diagnosis and management of bronchopulmonary dysplasia. BMJ2021; 375: n1974. https://doi.org/10.1136/bmj.n1974
3.
SiffelCKistlerKDLewisJFM, et al.Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review. J Matern Fetal Neonatal Med2021; 34(10): 1721–1731. https://doi.org/10.1080/14767058.2019.1646240
4.
TengMWuTJJingX, et al.Temporal dynamics of oxidative stress and inflammation in bronchopulmonary dysplasia. Int J Mol Sci2024; 25(18): 10145. https://doi.org/10.3390/ijms251810145
5.
ShahzadTRadajewskiSChaoCM, et al.Pathogenesis of bronchopulmonary dysplasia: when inflammation meets organ development. Mol Cell Pediatr2016; 3: 23. https://doi.org/10.1186/s40348-016-0051-9
NardielloCMižíkováIMortyRE. Looking ahead: where to next for animal models of bronchopulmonary dysplasia?Cell Tissue Res2017; 367(3): 457–468. https://doi.org/10.1007/s00441-016-2534-3
9.
ChenCMChouHC. Human mesenchymal stem cells attenuate hyperoxia-induced lung injury through inhibition of the renin–angiotensin system in newborn rats. Am J Transl Res2018; 10(8): 2628–2635. eCollection 2018.
10.
ZafarullahMLiWQSylvesterJ, et al.Molecular mechanisms of N-acetylcysteine actions. Cell Mol Life Sci2003; 60(1): 6–20. https://doi.org/10.1007/s000180300001
11.
SenerGTosunOSehirliAO, et al.Melatonin and N-acetylcysteine have beneficial effects during hepatic ischemia and reperfusion. Life Sci2003; 72(24): 2707–2718. https://doi.org/10.1016/s0024-3205(03)00187-5
12.
NagataKIwasakiYYamadaT, et al.Overexpression of manganese superoxide dismutase by N-acetylcysteine in hyperoxic lung injury. Respir Med2007; 101(4): 800–807. https://doi.org/10.1016/j.rmed.2006.07.017
13.
FalcigliaHSJohnsonJRSullivanJA, et al.Role of antioxidant nutrients and lipid peroxidation in premature infants with respiratory distress syndrome and bronchopulmonary dysplasia. Am J Perinatol2003; 20(2): 97–107. https://doi.org/10.1055/s-2003–38315
14.
StoneCAMcEvoyCTAschnerJL, et al.Update on vitamin E and its potential role in preventing or treating bronchopulmonary dysplasia. Neonatology2018; 113(4): 366–378. https://doi.org/10.1159/000487388
WarnerBBStuartLAPapesRA, et al.Functional and pathological effects of prolonged hyperoxia in neonatal mice. Am J Physiol1998; 275(1): L110–L117. https://doi.org/10.1152/ajplung.1998.275.1.L110
20.
ChuangICLiuDDKaoSJ, et al.N-acetylcysteine attenuates the acute lung injury caused by phorbol myristate acetate in isolated rat lungs. Pulm Pharmacol Ther2007; 20(6): 726–733. https://doi.org/10.1016/j.pupt.2006.08.010
InciIZhaiWArniS, et al.N-acetylcysteine attenuates lung ischemia-reperfusion injury after lung transplantation. Ann Thorac Surg2007; 84(1): 240–246. https://doi.org/10.1016/j.athoracsur.2007.03.082
23.
JohnsonSTBigamDLEmaraM, et al.Effects of N-acetylcysteine on intestinal reoxygenation injury in hypoxic newborn piglets resuscitated with 100% oxygen. Neonatology2009; 96(3): 162–170. https://doi.org/10.1159/000210089
24.
MüllerBHochscheidRSeifartC, et al.Alpha-tocopherol improves impaired physiology of rat type II pneumocytes isolated from experimentally injured lungs. Eur J Clin Invest2000; 30(11): 1018–1026. https://doi.org/10.1046/j.1365-2362.2000.00730.x
25.
KokluEGunesTGunesI, et al.Influence of maternal nicotine exposure on neonatal rat bone: protective effect of ascorbic acid. Am J Perinatol2006; 23(6): 387–395. https://doi.org/10.1055/s-2006-951287
26.
MaritzGSVan WykG. Influence of maternal nicotine exposure on neonatal rat lung structure: protective effect of ascorbic acid. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol1997; 117(2): 159–165. https://doi.org/10.1016/s0742-8413(96)00052-7
27.
EckersonHWWyteCMLa DuBN. The human serum paraoxonase/arylesterase polymorphism. Am J Hum Genet1983; 35(6): 1126–1138.
28.
HaagenLBrockA. A new automated method for phenotyping arylesterase (E.C.3.1.1.2.) based upon inhibition of enzymatic hydrolysis of 4-nitrophenyl acetate by phenyl acetate. Eur J Clin Chem Clin Biochem1992; 30(7): 391–395. https://doi.org/10.1515/cclm.1992.30.7.391
29.
ErelO. A novel automated direct measurement method for total antioxidant capacity using new generation, more stable ABTS radical cation. Clin Biochem2004; 37(4): 277–285. https://doi.org/10.1016/j.clinbiochem.2003.11.015
Nourooz-ZadehJ. Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma. Methods Enzymol1999; 300: 58–62. https://doi.org/10.1016/s0076-6879(99)00113-5
33.
EndesfelderSBührerC. Caffeine protects against hyperoxia-induced structural lung injury and restores alveolar development in neonatal rats. Antioxidants2025; 14(12): 1497. https://doi.org/10.3390/antiox14121497
34.
XieBLiSBaiW, et al.Artesunate alleviates hyperoxia-induced lung injury in neonatal mice by inhibiting NLRP3 inflammasome activation. Evid Based Complement Alternat Med2023; 2023: 7603943. https://doi.org/10.1155/2023/7603943
35.
KumarSBhagatPPandeyS, et al.The role of antioxidant agent (N-acetylcysteine) in oleic acid-induced acute lung injury in a rat model. Cureus2022; 14(9): e29478. https://doi.org/10.7759/cureus.29478
36.
KesidouEBitsinaCChatzisotiriouA, et al.N-acetylcysteine administration attenuates sensorimotor impairments following neonatal hypoxic-ischemic brain injury in rats. Int J Mol Sci2022; 23(24): 16175. https://doi.org/10.3390/ijms232416175
37.
AholaTLapattoRRaivioKO, et al.N-acetylcysteine does not prevent bronchopulmonary dysplasia in immature infants: a randomized controlled trial. J Pediatr2003; 143(6): 713–719. https://doi.org/10.1067/S0022-3476(03)00419-0
38.
BuhimschiCSBahtiyarMOZhaoG, et al.Antenatal N-acetylcysteine to improve outcomes of premature infants with intra-amniotic infection and inflammation (triple I): randomized clinical trial. Pediatr Res2021; 89(2): 175–184. https://doi.org/10.1038/s41390-020-01106-w
39.
MohammedCJLamichhaneSConnollyJA, et al.A PON for all seasons: comparing paraoxonase enzyme substrates, activity and action including the role of PON3 in health and disease. Antioxidants2022; 11(3): 590. https://doi.org/10.3390/antiox11030590
40.
CostaLGGiordanoGColeTB, et al.Paraoxonase 1 (PON1) as a genetic determinant of susceptibility to organophosphate toxicity. Toxicology2013; 307(1–3): 115–122. https://doi.org/10.1016/j.tox.2012.07.011
41.
BaydasGKaratasFGursuMF, et al.Antioxidant vitamin levels in term and preterm infants and their relation to maternal vitamin status. Arch Med Res2002; 33(3): 276–280. https://doi.org/10.1016/s0188-4409(02)00356-9
42.
TuZGuoHGaoY, et al.Macrophage pyroptosis mediates hyperoxia-induced inflammatory lung injury in neonates. Front Immunol2025; 16: 1546986. https://doi.org/10.3389/fimmu.2025.1546986
43.
TengMWuTJPritchardKAJr, et al.The destructive cycle in bronchopulmonary dysplasia: the rationale for systems pharmacology therapeutics. Antioxidants2025; 14(7): 844. https://doi.org/10.3390/antiox14070844
